Patent holdings for IPC class A61K 31/165

Total number of patents in this class: 3627

10-year publication summary

223
242
249
245
279
270
261
214
225
180
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
The Regents of the University of California
20289
50
Newron Pharmaceuticals S.p.A.
62
40
Novartis AG
10623
30
Les Laboratoires Servier
523
29
LTS Lohmann Therapie-Systeme AG
716
27
Murray and Poole Enterprises Limited
26
22
Allergan, Inc.
2314
20
Axsome Malta Ltd.
78
20
The General Hospital Corporation
4797
19
President and Fellows of Harvard College
6036
17
Indiana University Research and Technology Corporation
797
17
Board of Regents, The University of Texas System
5938
16
BIAL - Portela & CA, S.A.
222
16
Vanda Pharmaceuticals, Inc.
369
16
Dana-Farber Cancer Institute, Inc.
2623
15
Bristol-myers Squibb Company
4820
14
Children's Medical Center Corporation
1911
14
Dompé Farmaceutici S.p.A.
277
14
The United States of America, as represented by the Secretary, Department of Health and Human Services
2911
14
The Trustees of the University of Pennsylvania
4384
13
Other owners 3204